Van Peer A - Search Results

1

Pharmacokinetics of lubeluzole (Prosynap) after single intravenous doses in healthy subjects.

Van de Velde V, Crabbe R, Van Peer A, Woestenborghs R, Van Osselaer N, Hantson L, Heykants J. Van de Velde V, et al. Among authors: van osselaer n, van peer a. Int J Clin Pharmacol Ther. 1998 Sep;36(9):490-3. Int J Clin Pharmacol Ther. 1998. PMID: 9760010 Clinical Trial.

2

Single-dose and steady-state pharmacokinetics of sabeluzole in senile dementia of Alzheimer type patients.

De Deyn PP, Van de Velde V, Verslegers W, Saerens J, Pickut BA, Clincke B, Woestenborghs R, Van Peer A. De Deyn PP, et al. Among authors: van de velde v, van peer a. Eur J Clin Pharmacol. 1992;43(6):661-2. doi: 10.1007/BF02284969. Eur J Clin Pharmacol. 1992. PMID: 1493851

3

The effects of food and dose on the oral systemic availability of itraconazole in healthy subjects.

Van Peer A, Woestenborghs R, Heykants J, Gasparini R, Gauwenbergh G. Van Peer A, et al. Eur J Clin Pharmacol. 1989;36(4):423-6. doi: 10.1007/BF00558308. Eur J Clin Pharmacol. 1989. PMID: 2544431 Clinical Trial.

4

Pharmacokinetics of the novel antipsychotic agent risperidone and the prolactin response in healthy subjects.

Huang ML, Van Peer A, Woestenborghs R, De Coster R, Heykants J, Jansen AA, Zylicz Z, Visscher HW, Jonkman JH. Huang ML, et al. Among authors: van peer a. Clin Pharmacol Ther. 1993 Sep;54(3):257-68. doi: 10.1038/clpt.1993.146. Clin Pharmacol Ther. 1993. PMID: 7690693

5

The implications of non-linear red blood cell partitioning for the pharmacokinetics and pharmacodynamics of the nucleoside transport inhibitor draflazine.

Snoeck E, Jacqmin P, Van Peer A, Danhof M, Ver Donck K, Van Belle H, Woestenborghs R, Crabbé R, Van Gool R, Dupont A, Heykants J. Snoeck E, et al. Among authors: van gool r, van belle h, van peer a. Br J Clin Pharmacol. 1996 Nov;42(5):605-13. doi: 10.1111/j.1365-2125.1996.tb00116.x. Br J Clin Pharmacol. 1996. PMID: 8951192 Free article.

6

Population analysis of the non linear red blood cell partitioning and the concentration-effect relationship of draflazine following various infusion rates.

Snoeck E, Piotrovskij V, Jacqmin P, Van Peer A, Danhof M, Ver Donck K, Woestenborghs R, Van Belle H, Van Bortel L, Van Gool R, Dupont AG, Heykants J. Snoeck E, et al. Among authors: van gool r, van belle h, van bortel l, van peer a. Br J Clin Pharmacol. 1997 Jun;43(6):603-12. doi: 10.1046/j.1365-2125.1997.00593.x. Br J Clin Pharmacol. 1997. PMID: 9205820 Free PMC article. Clinical Trial.

7

Population analysis of the non-linear red blood cell partitioning of draflazine following various infusion durations.

Snoeck E, Piotrovskij V, Jacqmin P, Lins RL, Van Peer A, Danhof M, Woestenborghs R, Van Gool R, Dupont AG, Heykants J. Snoeck E, et al. Among authors: van gool r, van peer a. Eur J Clin Pharmacol. 1997;53(1):57-63. doi: 10.1007/s002280050337. Eur J Clin Pharmacol. 1997. PMID: 9349931 Clinical Trial.

8

Safety and pharmacokinetics of the neuroprotective drug lubeluzole in patients with ischemic stroke.

De Keyser J, Van de Velde V, Schellens RL, Hantson L, Tritsmans L, Gheuens J, Van Peer A, Woestenborghs R, Franke CL, van Gorp J. De Keyser J, et al. Among authors: van gorp j, van de velde v, van peer a. Clin Ther. 1997 Nov-Dec;19(6):1340-51. doi: 10.1016/s0149-2918(97)80009-4. Clin Ther. 1997. PMID: 9444444 Clinical Trial.

9

Effect of food on the pharmacokinetics of a new hydroxypropyl-beta-cyclodextrin formulation of itraconazole.

Van de Velde VJ, Van Peer AP, Heykants JJ, Woestenborghs RJ, Van Rooy P, De Beule KL, Cauwenbergh GF. Van de Velde VJ, et al. Among authors: van peer ap, van rooy p. Pharmacotherapy. 1996 May-Jun;16(3):424-8. Pharmacotherapy. 1996. PMID: 8726601 Clinical Trial.

10

Galantamine pharmacokinetics, safety, and tolerability profiles are similar in healthy Caucasian and Japanese subjects.

Zhao Q, Brett M, Van Osselaer N, Huang F, Raoult A, Van Peer A, Verhaeghe T, Hust R. Zhao Q, et al. Among authors: van osselaer n, van peer a. J Clin Pharmacol. 2002 Sep;42(9):1002-10. J Clin Pharmacol. 2002. PMID: 12211216 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

121 results

Search Page

Filters